Aurobindo Pharma’s wholly owned subsidiary Auro Pharma acquires Khandelwal Laboratories’ non-oncology prescription ...

Multiple experts are converging on select pharma, FMCG, media, and financial services counters. Key names on today’s radar ...

Aurobindo Pharma said the decision is aligned with CuraTeQ's strategic portfolio prioritisation. As per the arrangement, ...

Aurobindo Pharma’s wholly owned arm Helix Healthcare will acquire an additional 20% stake in Luoxin Aurovitas Pharma in China for $5.1 million, strengthening its inhalation manufacturing footprint.

After a rough regulatory start to the year, India’s Aurobindo Pharma is charting plans for growth. The Hyderabad-based generics juggernaut will plow 3 billion Indian rupees (about $37.7 million) into ...

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Auro Pharma Limited, has approved the ...

Hyderabad, India. (6th September, 2010) - Aurobindo Pharma is pleased to announce that it has entered into licensing and supply agreements with AstraZeneca, one of the world's leading ...

Aurobindo Pharma acquires Khandelwal Labs' non-oncology portfolio for ₹325 crore, enhancing its anti-infective and pain ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75mg, which is being launched. Clopidogrel Tablets USP ...

Aurobindo Ltd. and Aurobindo USA were hit with a patent infringement lawsuit on Oct. 9 in Delaware District Court. The action, brought by McCarter & English and Arnold & Porter Kaye Scholer on behalf ...

HYDERABAD: Pharma major Aurobindo Pharma is acquiring the non-oncology prescription business of Mumbai-based Khandelwal ...